Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To assess the safety/tolerability of 52 weeks of treatment with QVA149 (110μg indacaterol/50μg glycopyrrolate) once a day on adverse event reporting rate in patients with moderate or severe Chronic Obstructive Pulmonary Disease (COPD)
Inclusion criteria
- Chronic Obstructive Pulmonary Disease (COPD)